Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-026489
Filing Date
2024-11-12
Accepted
2024-11-12 08:01:10
Documents
1
Period of Report
2024-11-11

Document Format Files

Seq Description Document Type Size
1 form4-11122024_011107.html 4  
1 form4-11122024_011107.xml 4 3383
  Complete submission text file 0001415889-24-026489.txt   5007
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Issuer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 66 COLD HILL DRIVE MENDAHM NJ 07945
Business Address
Marucci Anthony S (Reporting) CIK: 0001429933 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15006 | Film No.: 241443509